tiprankstipranks
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX

Celldex (CLDX) Income Statement

972 Followers

Celldex Income Statement

Last quarter (Q3 2023), Celldex's total revenue was $1.52M, an increase of 272.73% from the same quarter last year. In Q3, Celldex's net income was $-38.26M. See Celldex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 4.37M$ 2.36M$ 4.65M$ 7.42M$ 3.57M$ 9.54M
Cost of Revenue
$ -100.00K$ 100.00K$ -100.00K---
Gross Profit
$ 4.37M$ 2.36M$ 4.65M---
Operating Expense
$ 139.16M$ 109.45M$ 73.80M$ 56.99M$ 58.10M$ 85.94M
Operating Income
$ -134.80M$ -115.23M$ -69.15M$ -49.57M$ -54.52M$ -76.40M
Net Non Operating Interest Income Expense
$ 10.19M$ 2.91M$ 505.00K---
Other Income Expense
-$ -6.86M$ 2.10M$ -11.38M$ 3.65M$ -75.55M
Pretax Income
$ -124.61M$ -112.33M$ -70.74M$ -60.95M$ -50.88M$ -151.95M
Tax Provision
$ -11.42M$ -17.48M$ -227.00K$ -1.17M$ 0.00$ -765.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -124.61M$ -112.33M$ -70.51M$ -59.78M$ -50.88M$ -151.18M
Basic EPS
$ -2.65$ -2.40$ -1.64$ -2.02$ -3.51$ -14.48
Diluted EPS
$ -2.65$ -2.40$ -1.64$ -2.02$ -3.51$ -14.48
Basic Average Shares
$ 188.62K$ 46.89K$ 42.87K$ 29.64M$ 14.51M$ 10.44M
Diluted Average Shares
$ 188.62K$ 46.89K$ 42.87K$ 29.64M$ 14.51M$ 10.44M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 139.06M$ 109.55M$ 73.70M$ 56.99M$ 58.10M$ 85.94M
Net Income From Continuing And Discontinued Operation
$ -124.61M$ -112.33M$ -70.51M$ -59.78M$ -50.88M$ -151.18M
Normalized Income
$ -54.32M--$ -48.62M$ -54.52M$ -76.02M
Interest Expense
------
EBIT
$ -126.01M$ -112.33M$ -70.74M$ -49.57M$ -54.52M$ -76.40M
EBITDA
$ -88.53M$ -108.58M$ -70.88M$ -45.64M$ -49.67M$ -72.60M
Currency in USD

Celldex Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis